Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin E, Folic Acid, Saw Palmetto, Psyllium Health Claims To Be Requested

This article was originally published in The Tan Sheet

Executive Summary

Four health claims petitions for dietary supplements containing vitamin E, folic acid/vitamins B6 and B12, saw palmetto and psyllium are being developed by the American Preventive Medical Association, Pure Encapsulations and a group of dietary supplement advocates including Julian Whitaker, MD, Durk Pearson and Sandy Shaw.

You may also be interested in...



Dietary Supplement Health Claims Data Requested By FDA

Scientific data or related information on four potential health claims for dietary supplements is solicited by FDA in a Sept. 8 Federal Register notice. The request is the agency's first public effort to deal with the recent D.C. federal appeals court decision in the Pearson v. Shalala case.

Dietary Supplement Health Claims Data Requested By FDA

Scientific data or related information on four potential health claims for dietary supplements is solicited by FDA in a Sept. 8 Federal Register notice. The request is the agency's first public effort to deal with the recent D.C. federal appeals court decision in the Pearson v. Shalala case.

Dietary Supplement Health Claims Data Requested By FDA

Scientific data or related information on four potential health claims for dietary supplements is solicited by FDA in a Sept. 8 Federal Register notice. The request is the agency's first public effort to deal with the recent D.C. federal appeals court decision in the Pearson v. Shalala case.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089857

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel